Mealey's (December 20, 2018, 1:42 PM EST) -- TRENTON, N.J. — A patent owner’s attempt to invoke Noerr-Pennington immunity from antitrust counterclaims levied by a generic drug maker was deemed premature on Dec. 19, when a New Jersey federal...
New Jersey Federal Judge Won’t Dismiss Antitrust Counterclaim In Patent Row
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login